Latest Breast cancer treatment Stories
Austin-based tech company, Photetica, is now in the clinical trial phase with its newest medical device, Lazarus, and has launched a crowdfunding campaign through Indiegogo to support clinical
Company to Report On Science And Progress Of DCVax-Direct Trial At World's Largest Cancer Conference BETHESDA, Md., April 22, 2014 /PRNewswire/ -- Northwest Biotherapeutics (NASDAQ:
In an innovative clinical trial led by UC San Francisco, the experimental drug neratinib along with standard chemotherapy was found to be a beneficial treatment for some women with newly diagnosed, high-risk breast cancer.
Champions TumorGrafts(TM) Provide Accurate Predictions of Treatments' Efficacy in 81 Percent of Evaluated Patients with Advanced Sarcoma HACKENSACK, N.J., April 8, 2014 /PRNewswire/
Metronomic algorithms for targeted therapy to improve value of response and "failed drugs" for "resistant women's cancers" NEW YORK, April 8, 2014 /PRNewswire/ -- The following will
A new genetic "signature" to identify prostate cancer patients who are at high risk of their cancer recurring after surgery or radiotherapy has been developed by researchers in Canada.
Cianna Medical, Inc.: Strut-based breast cancer radiation treatment could expand options for DCIS patients. Aliso Viejo, Calif.
Surgery for "operable" tumor is also possible but may not be necessary NEW YORK, April 1, 2014 /PRNewswire-USNewswire/ -- Hall of Fame quarterback Jim Kelly will start chemotherapy
UT Southwestern Medical Center researchers are developing a new predictive tool that could help patients with breast cancer and certain lung cancers decide whether follow-up treatments are likely to help.
- The deadly nightshade, Atropa Belladonna, which possesses stupefying or poisonous properties.
- A sleeping-potion; a soporific.
- To mutter deliriously.